Actively Recruiting
Immediate and Functional Results of Different Types of Reconstructions After Proximal Gastrectomy For Gastric and Esophagogastric Junction Cancer
Led by P. Herzen Moscow Oncology Research Institute · Updated on 2026-04-22
400
Participants Needed
1
Research Sites
230 weeks
Total Duration
On this page
Sponsors
P
P. Herzen Moscow Oncology Research Institute
Lead Sponsor
A
A.Loginov Moscow Clinical Scientific Center
Collaborating Sponsor
AI-Summary
What this Trial Is About
Proximal gastric and esophagogastric junction cancers comprise up to 40% of gastric malignancies. For localized disease, proximal gastrectomy is the main radical procedure, but reconstruction of GI tract often leads to significant functional issues. Rising use of proximal resections and broader indications have increased attention to postoperative quality of life (QoL). Common reconstructions include direct esophagogastrostomy (various types), double-tract reconstruction, jejunal interposition, and newer anti-reflux anastomoses (e.g., double-flap, overlap, tunnel techniques). Each method has unique pros and cons regarding reflux esophagitis, food passage, dumping syndrome, nutritional changes, and long-term QoL. No consensus exists on the optimal technique, leading to variable practices and outcomes. Most research focuses on oncologic radicality and survival, while functional results and QoL remain understudied. Systematic evaluation of functional outcomes across reconstruction types after proximal subtotal gastrectomy is needed in Russian Federation to improve QoL, advance research, and standardize treatment of proximal gastric and EGJ cancers.
CONDITIONS
Official Title
Immediate and Functional Results of Different Types of Reconstructions After Proximal Gastrectomy For Gastric and Esophagogastric Junction Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with clinically confirmed primary gastric or esophagogastric junction cancer (including Siewert Types II and III) cT1-3N0-2M0
- Undergoing proximal gastrectomy with curative intent by open, laparoscopic, or robotic surgery
- Surgery planned between January 1, 2025 and December 31, 2026
- All consecutive eligible patients during this period
You will not qualify if you...
- Presence of metastatic disease or positive peritoneal cytology from prior staging laparoscopy
- Diagnosis of Siewert Type I esophagogastric junction cancer
- Emergency surgery or surgery without curative intent
- Additional surgeries beyond curative surgery for primary esophageal or esophagogastric junction cancer
- Previous surgery on the stomach or colon
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
P.Herzen Moscow Oncological Research Institute
Moscow, Russia
Actively Recruiting
Research Team
A
Andrey Ryabov, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here